P117 Limitation of donor specific antibody mean florescent intensity values in predicting transplant compatibility: The saga continues

Virtual Crossmatch in the Context of Kidney Transplantation

“…In this context, use a fixed cutoff for VXM may not be an adequate option, in fact there is no single value that corresponds to a threshold above or below which contraindicated the transplantation without risk [18]. VXM allow for the quantification of antibodies by MFI and patient stratification by risk groups (sensitization), therefore it should be used with aim of favoring hyper sensitized patients and not excluding them from being tested in real crossmatch (CDC e FCXM) [19], which suggests that the methods are complementary [8,20,21].…”